Allworth Financial’s Dr. Reddy's Laboratories RDY Stock Holding History
Bought
Maintained
Sold
Other funds holding RDY
AIM
Allworth Financial's RDY Position: Q2 2026 in Review
Allworth Financial reduced its Dr. Reddy's Laboratories (RDY) stake by 50% in Q2 2026, selling an estimated $109K and leaving 8,062 shares worth $117K. The position accounts for ﹤0.01% of the portfolio, ranked #1850.
Allworth Financial first reported a position in RDY in Q2 2022 and has held it in 17 quarters since. The position peaked at $223K in Q1 2026. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.
- Allworth Financial held 8,062 shares of Dr. Reddy's Laboratories worth $117K as of Q2 2026.
- Allworth Financial sold 8,054 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $109K.
- Dr. Reddy's Laboratories made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #1850 holding.
- Allworth Financial first reported a position in Dr. Reddy's Laboratories in Q2 2022 and has held it in 17 quarters since.
- Allworth Financial's Dr. Reddy's Laboratories position peaked at $223K in Q1 2026.
- 238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.
Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.